BioMarin Pharmaceutical, Inc. (BMRN)
59.66
+1.85
(+3.20%)
USD |
NASDAQ |
Feb 10, 16:00
60.61
+0.95
(+1.59%)
After-Hours: 07:34
BioMarin Pharmaceutical Market Cap : 11.46B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.412B |
| Merck & Co., Inc. | 290.77B |
| Gilead Sciences, Inc. | 182.67B |
| AbbVie, Inc. | 393.14B |
| Amgen, Inc. | 196.55B |
Market Cap Related Metrics
| PE Ratio | 22.35 |
| PS Ratio | 3.782 |
| PEG Ratio | 0.3682 |
| Price to Book Value | 1.892 |
| Price to Free Cash Flow | 14.13 |
| Price | 59.66 |
| Earnings Yield | 4.47% |
| PEGY Ratio | 0.3682 |
| Operating PE Ratio | 13.64 |
| Normalized PE Ratio | 16.72 |